It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage.
Doctors also expect some patients will hesitate to take Leqembi due to its limited impact and potential side effects. They say it will take years to learn how best to deploy the drug and that work must be done to improve diagnosis.
“This is the start of a very exciting journey,” said Dr. Ambar Kulshreshtha, a suburban Atlanta family physician focused on dementia patients.
More than 6 million Americans, and millions more worldwide, have Alzheimer’s disease, the most common cause of dementia. There’s no cure, but Leqembi clears a sticky brain protein called amyloid that’s a key indicator of Alzheimer’s.
Studies showed that it can delay the progression of the disease by a few months when given to people with mild symptoms. Some experts say the delay may be too subtle for patients to notice.
Related articles
Kate Hudson hits the stage to debut songs from her new album Glorious at star
Kate Hudson looked like a pro as she performed songs from her new album Glorious for the first time.2024-05-21- Anya Taylor-Joy rocked two separate outfits while spreading the word about her new movie Furiosa in2024-05-21
Biden revives effort to lower costs of caregiving for families
WASHINGTON (AP) — As President Joe Biden runs for reelection, he’s resurrecting proposals to reshape2024-05-21- Jennifer Garner is twinning with her oldest child in their Sunday finest.The Golden Globe winner, 522024-05-21
Lynn Williams breaks NWSL goal
Lynn Williams scored her 79th league goal, becoming the National Women’s Soccer League all-time scor2024-05-21Scenes from Israel and Gaza reflect dashed hopes as imminent cease
JERUSALEM (AP) — An announcement by Hamas late Monday that it had accepted a cease-fire proposal sen2024-05-21
atest comment